Fungal infections affect over 1 billion people, with mortality rates estimated at 1-2 million annually. Advancements in modern medicine, including bone marrow and solid organ transplants or anti-neoplastic chemotherapy have induced a major uptick in the incidence of opportunistic fungal infections.

Market Analysis and Insights: Global Fungal Testing Kit Market
The global Fungal Testing Kit market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Fungal Testing Kit Scope and Market Size
The global Fungal Testing Kit market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fungal Testing Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Molecular Test
Chromogenic Test
Others

Segment by Application
Diagnostic Laboratory
Hospitals
Pharmaceutical Companies
Research and Academic Institutes

The Fungal Testing Kit market is analysed and market size information is provided by regions (countries). Segment by Application, the Fungal Testing Kit market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Merck KGaA
Thermo Fisher Scientific
bioMerieux SA
ELITech Group
PerkinElmer
GenMark Diagnostics Inc.
Norgen Biotek
C.P.M Diagnostic Research SAS
Biomed Diagnostics
PCRmax
Roche
Hologic
Bioquochem